IMAGE: Lung squamous cell carcinoma

Multimedia

Showing multimedia 41-50 out of 172.

<  Previous | 3 | 4 | 5 | 6 | 7 | Next  >

Key:    Image    Video    Audio

The Dangerous Side Effects of 'Cross Reactive' T Cells (4 of 4)

The Dangerous Side Effects of 'Cross Reactive' T Cells (4 of 4)
This video shows actively beating iCells. This video relates to a paper that appeared in the Aug. 7, 2013, issue of Science Translational Medicine, published by AAAS. The paper, by B.J. Cameron...

Contact: Science Press Pacakge
scipak@aaas.org
202-326-6440
American Association for the Advancement of Science

The Dangerous Side Effects of 'Cross Reactive' T Cells (3 of 4)

The Dangerous Side Effects of 'Cross Reactive' T Cells (3 of 4)
This is a schematic showing T cells engaging and killing a cancer cell. This image relates to a paper that appeared in the Aug. 7, 2013, issue of Science Translational Medicine, published by ...

Contact: Science Press Pacakge
scipak@aaas.org
202-326-6440
American Association for the Advancement of Science

The Dangerous Side Effects of 'Cross Reactive' T Cells (2 of 4)

The Dangerous Side Effects of 'Cross Reactive' T Cells (2 of 4)
T cells (shown in blue) are killing cancer cells (shown in red). This image relates to a paper that appeared in the Aug. 7, 2013, issue of Science Translational Medicine, published by AAAS. The...

Contact: Science Press Pacakge
scipak@aaas.org
202-326-6440
American Association for the Advancement of Science

The Dangerous Side Effects of 'Cross Reactive' T Cells (1 of 4)

The Dangerous Side Effects of 'Cross Reactive' T Cells (1 of 4)
T cells (shown in blue) are killing cancer cells (shown in red). This image relates to a paper that appeared in the Aug. 7, 2013, issue of Science Translational Medicine, published by AAAS. The...

Contact: Science Press Pacakge
scipak@aaas.org
202-326-6440
American Association for the Advancement of Science

Richard I. Fisher, Fox Chase Cancer Center

Richard I. Fisher, Fox Chase Cancer Center
This is Richard I. Fisher, M.D., who was named president and CEO of Fox Chase Cancer Center.

Contact: Diana Quattrone
diana.quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center

Maintenance Therapy for Metastatic Colorectal Cancer: Practice before Evidence?

Maintenance Therapy for Metastatic Colorectal Cancer: Practice before Evidence?
F. Ciardiello shares his comments on perspectives and potentials to change the current practice in the management of metastatic colorectal cancer, based on results from two studies on maintenance ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

Nationwide NSCLC Study Provides Data on the Value of Molecular Screening for Targeted Treatment

Nationwide NSCLC Study Provides Data on the Value of Molecular Screening for Targeted Treatment
R. Dziadziuszko underlines the importance of widening the range of screened biomarkers, the potential benefits in terms of treatment appropriateness for patients and the added value of broad ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

Radioactive Iodine-Refractory Thyroid Cancer: Sorafenib, a New Treatment Option

Radioactive Iodine-Refractory Thyroid Cancer: Sorafenib, a New Treatment Option
L. Licitra shares her comments about randomized, phase III DECISION trial that studied sorafenib, an orally active inhibitor of VEGFR1-3 and Raf kinases, vs. placebo in patients with progressive ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

Amplification of c-MET: A Study of Resistance to Anti-EGFR Therapies in Colorectal Cancer

Amplification of c-MET: A Study of Resistance to Anti-EGFR Therapies in Colorectal Cancer
F. Ciardiello shares his comments on a next generation sequencing study applied to identify genetic alterations in patients with metastatic colorectal cancer who do not develop K-ras mutations during ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

Novelties to Target Immune Pathways in Cancer

Novelties to Target Immune Pathways in Cancer
Giuseppe Curigliano offers an overview on current cancer research focused on T-regulators and T-effectors and opens hopes for future progress studying ways to re-activate the immune system and ...

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology

Showing multimedia 41-50 out of 172.

<  Previous | 3 | 4 | 5 | 6 | 7 | Next  >

  Search News Releases

     

 

 

EurekAlert!